Navigation Links
DrugRisks Update: Warning Added to Pradaxa For Blood Condition
Date:5/8/2013

Chicago, IL (PRWEB) May 08, 2013

The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. The maker of the drug recently updated label warnings to include the risk of a blood platelet disorder*.

DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional anticoagulants. The FDA has stated the drug is as safe as warfarin**. However, the Institute for Safe Medication Practices recently ranked drugs like Pradaxa among the most dangerous, and warned that Pradaxa bleeding may be 5 times as likely to result in death than bleeding from warfarin or Coumadin***.

The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.

Now, DrugRisks has learned that the maker of the drug, Boehringer Ingelheim, recently added a new Pradaxa side effect warning to the label advising of the risk of thrombocytopenia, a drop in blood platelets that can result in Pradaxa internal bleeding*.

With a growing number of patients filing a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Boehringer Ingelheim, 4/30/13; us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2013/04-30-13-boehringer-ingelheim-pharmaceuticals-prescribing-information-pradaxa-dabigatran-etexilate-mesylate.html
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects/prweb10709493.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
2. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
3. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
4. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
5. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
8. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
9. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
10. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
11. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores Family Law ... Association’s third Vice President earlier this year. She will serve the membership in this capacity ... President, in accordance with the organization’s by-laws. , Musielak joined the Andrew ...
(Date:7/26/2017)... ... ... The number of adults 65 years or older is expected to more ... in the population are not well described. In a study published in The Journal ... the American Academy of Allergy, Asthma & Immunology (AAAAI), researchers identified factors associated with ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... Summers in ... up the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high ... gift shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and ...
(Date:7/25/2017)... MOORE, OK (PRWEB) , ... July 25, 2017 ... ... are proud to announce the launch of their partnership to provide the ... is the first pharmacy-focused platform in the country with the ability to develop ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/19/2017)... N.C. , July 19, 2017  Mako Medical ... Affairs, and the Military Family Assistance Fund (MFA) to ... to visit with their families one last ... funding to coordinate the travel and logistics needed for ... our deployed soldiers and their families. We just wish ...
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
Breaking Medicine Technology: